AIDS
Most Read
Patient Zero in AIDS crisis was misidentified, study says, rewriting early history of virus
CRISPR identifies genes that might be targeted to hobble HIV infection
The drug pricing crusader at the center of one of the nastiest fights of the election season
STAT Plus: Pharmalot, Pharmalittle: Novartis to spend $200 million to promote its flagging heart drug
Gilead defeats AIDS activists who claimed the company manipulated patents
Pharmalot, Pharmalittle: Pharma faces challenges as AIDS patients live longer
An AIDS-free world is possible, but do we have the will to achieve it?
All Coverage
advertisement
